Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome

Citations Over TimeTop 19% of 2017 papers

Abstract

Noonan syndrome (NS) is caused by mutations in RAS/ERK pathway genes, and is characterized by craniofacial, growth, cognitive and cardiac defects. NS patients with kinase-activating RAF1 alleles typically develop pathological left ventricular hypertrophy (LVH), which is reproduced in Raf1L613V/+ knock-in mice. Here, using inducible Raf1L613V expression, we show that LVH results from the interplay of cardiac cell types. Cardiomyocyte Raf1L613V enhances Ca2+ sensitivity and cardiac contractility without causing hypertrophy. Raf1L613V expression in cardiomyocytes or activated fibroblasts exacerbates pressure overload-evoked fibrosis. Endothelial/endocardial (EC) Raf1L613V causes cardiac hypertrophy without affecting contractility. Co-culture and neutralizing antibody experiments reveal a cytokine (TNF/IL6) hierarchy in Raf1L613V-expressing ECs that drives cardiomyocyte hypertrophy in vitro. Furthermore, postnatal TNF inhibition normalizes the increased wall thickness and cardiomyocyte hypertrophy in vivo. We conclude that NS-cardiomyopathy involves cardiomyocytes, ECs and fibroblasts, TNF/IL6 signalling components represent potential therapeutic targets, and abnormal EC signalling might contribute to other forms of LVH.

Related Papers

• → Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy(2018)44 cited
• → 671 Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload(2003)4 cited
• [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].(1982)
• [Apoptosis in pressure overload-induced heart hypertrophy].(2001)
• → Abstract 2375: Regulation of Cardiac Myocyte Contractility by Phospholemman(2008)